Dr. Sloan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Bader 4
Boston, MA 02115Phone+1 617-355-6268
Education & Training
University of Pennsylvania Health SystemFellowship, Blood Banking/Transfusion Medicine, 1994 - 1996- University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1990 - 1994
New York University School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1997 - Present
MA State Medical License 2000 - 2022
PA State Medical License 1993 - 1996
American Board of Pathology Clinical Pathology
Clinical Trials
- Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) Start of enrollment: 2008 Apr 01
Publications & Presentations
PubMed
- Executive Summary: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE (PEACE) Consensus Conference.Peta M A Alexander, Melania M Bembea, Katherine Cashen, Ira M Cheifetz, Heidi J Dalton
Pediatric Critical Care Medicine. 2024-07-01 - 4 citationsProphylactic Transfusion Strategies in Children Supported by Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation Col...Marianne E Nellis, Katie M Moynihan, Steven R Sloan, Meghan Delaney, Martin C J Kneyber
Pediatric Critical Care Medicine. 2024-07-01 - 8 citationsAssociations between ABO non-identical platelet transfusions and patient outcomes-A multicenter retrospective analysis.Daniel W Bougie, Sarah E Reese, Rebecca J Birch, Deborah B Bookwalter, Patrick K Mitchell
Transfusion. 2023-05-01
Press Mentions
By Steven L Spitalnik Md Clinical Pathology Board Review 1e 1 Harpsc PaperbackJune 27th, 2020
Targeted Genomic CRISPR-Cas9 Screen Identifies MAP4K4 as Essential for Glioblastoma InvasionSeptember 30th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
